{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:03:26Z","timestamp":1783562606088,"version":"3.55.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Addenbrooke\u2019s Charitable Trust","award":["900218"],"award-info":[{"award-number":["900218"]}]},{"name":"Ferblanc"},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["Seedcorn2020\\100084"],"award-info":[{"award-number":["Seedcorn2020\\100084"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["Developing Concept Fund"],"award-info":[{"award-number":["Developing Concept Fund"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["Confidence in Concept"],"award-info":[{"award-number":["Confidence in Concept"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRC, MR\/S005528\/1"],"award-info":[{"award-number":["MRC, MR\/S005528\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["100"],"award-info":[{"award-number":["100"]}],"id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["Clinician Scientist Award"],"award-info":[{"award-number":["Clinician Scientist Award"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative condition with the greatest increase in disability globally. Dysfunction of dopaminergic neurons is a well-known PD hallmark; however, changes in astrocytes also accompany PD progression. One aspect of astrocyte biology not yet investigated in PD is their network coupling. To assess this, we focussed on the major astrocytic gap junctional protein connexin 43 (Cx43, GJA1). A dataset of 20 post-mortem late-stage PD brain tissue samples from the cortex and basal ganglia alongside 20 age-matched control sets was collected, accompanied by clinical histories and data on \u03b1-synuclein, tau, and amyloid-\u03b2 pathology. Protein levels and intracellular distribution of Cx43 and other key markers were measured. Computational re-analysis of open-source mRNA sequencing datasets from the striatum and midbrain complemented the original findings. Two novel observations were made: first, profound Cx43 loss in late-stage PD, and second, differential manifestation of this pathology in different brain areas, including those outside of the midbrain substantia nigra\u2014the region that is most commonly used in PD research. Cx43 downregulation in specific regions correlated with non-motor symptoms of PD such as depression and sleep disturbance. Astrocytic tree simplification in the frontal cortex was further observed. In conclusion, astrocytic network decoupling through Cx43 downregulation in PD may contribute to astrocytic dysfunction and PD symptom development.<\/jats:p>","DOI":"10.1038\/s41598-025-94188-7","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:14:40Z","timestamp":1742940880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Connexin 43 is downregulated in advanced Parkinson\u2019s disease in multiple brain regions which correlates with symptoms"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5376-339X","authenticated-orcid":false,"given":"Nataly","family":"Hastings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw Aleksander","family":"Stempor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Wayland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Kuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R. N.","family":"Kotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"94188_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-021-00272-w","volume":"8","author":"O Okunoye","year":"2022","unstructured":"Okunoye, O., Marston, L., Walters, K. & Schrag, A. Change in the incidence of Parkinson\u2019s disease in a large UK primary care database. NPJ Park. Dis. 8, 1\u20137 (2022).","journal-title":"NPJ Park. Dis."},{"key":"94188_CR2","unstructured":"Parkinson\u2019s_UK. The Incidence and Prevalence of Parkinson\u2019s in the UK. (2017)."},{"key":"94188_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.10513","volume":"53","author":"O Rascol","year":"2003","unstructured":"Rascol, O. et al. Limitations of current Parkinson\u2019s disease therapy. Ann. Neurol. 53, 3\u201315 (2003).","journal-title":"Ann. Neurol."},{"key":"94188_CR4","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202107","author":"J Andrejack","year":"2020","unstructured":"Andrejack, J. & Mathur, S. What people with Parkinson\u2019s disease want. J. Parkinsons. Dis. https:\/\/doi.org\/10.3233\/JPD-202107 (2020).","journal-title":"J. Parkinsons. Dis."},{"key":"94188_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","volume":"21","author":"NI Bohnen","year":"2022","unstructured":"Bohnen, N. I. et al. Cholinergic system changes in Parkinson\u2019s disease: Emerging therapeutic approaches. Lancet Neurol. 21, 381\u2013392 (2022).","journal-title":"Lancet Neurol."},{"key":"94188_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3727\/096368908784423328","volume":"17","author":"AJ Monahan","year":"2008","unstructured":"Monahan, A. J., Warren, M. & Carvey, P. M. Neuroinflammation and peripheral immune infiltration in Parkinson\u2019s disease: An autoimmune hypothesis. Cell Transpl. 17, 363\u2013372 (2008).","journal-title":"Cell Transpl."},{"key":"94188_CR7","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.neuron.2018.08.015","volume":"99","author":"X Yu","year":"2018","unstructured":"Yu, X. et al. Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. Neuron 99, 1170-1187.e9 (2018).","journal-title":"Neuron"},{"issue":"10","key":"94188_CR8","doi-asserted-by":"publisher","first-page":"110484","DOI":"10.1016\/j.celrep.2022.110484","volume":"38","author":"L H\u00f6sli","year":"2022","unstructured":"H\u00f6sli, L. et al. Decoupling astrocytes in adult mice impairs synaptic plasticity and spatial learning. Cell Rep. 38(10), 110484 (2022).","journal-title":"Cell Rep."},{"key":"94188_CR9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02971.x","author":"C Frisch","year":"2003","unstructured":"Frisch, C. et al. Mice with astrocyte-directed inactivation of connexin43 exhibit increased exploratory behaviour, impaired motor capacities, and changes in brain acetylcholine levels. Eur. J. Neurosci. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02971.x (2003).","journal-title":"Eur. J. Neurosci."},{"key":"94188_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth, H. D. E., Hirst, W. D. & Wade-Martins, R. The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci. 40, 358\u2013370 (2017).","journal-title":"Trends Neurosci."},{"key":"94188_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico, A. et al. Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep. 12, 213\u2013229 (2019).","journal-title":"Stem Cell Rep."},{"key":"94188_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.stemcr.2019.01.011","volume":"12","author":"MC Chai","year":"2019","unstructured":"Chai, M. C. & Kohyama, J. Non-cell-autonomous neurotoxicity in parkinson\u2019s disease mediated by astroglial \u03b1-synuclein. Stem Cell Rep. 12, 183\u2013185 (2019).","journal-title":"Stem Cell Rep."},{"key":"94188_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/brain\/awab446","volume":"145","author":"S Smajic","year":"2022","unstructured":"Smajic, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145, 964\u2013978 (2022).","journal-title":"Brain"},{"key":"94188_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00363-8","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. Human striatal glia differentially contribute to AD- and PD-specific neurodegeneration. Nat. Aging https:\/\/doi.org\/10.1038\/s43587-023-00363-8 (2023).","journal-title":"Nat. Aging"},{"key":"94188_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/glia.24295","volume":"71","author":"L Basurco","year":"2023","unstructured":"Basurco, L. et al. Microglia and astrocyte activation is region-dependent in the \u03b1-synuclein mouse model of Parkinson\u2019s disease. Glia 71, 571\u2013587 (2023).","journal-title":"Glia"},{"key":"94188_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak, H., Sastre, M. & Del Tredici, K. Development of \u03b1-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol. 114, 231\u2013241 (2007).","journal-title":"Acta Neuropathol."},{"key":"94188_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, Yh. & Takahashi, H. NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol. 99, 14\u201320 (2000).","journal-title":"Acta Neuropathol."},{"key":"94188_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/emmm.201302878","volume":"6","author":"C Proschel","year":"2014","unstructured":"Proschel, C., Stripay, J. L., Shih, C. H., Munger, J. C. & Noble, M. D. Delayed transplantation of precursor cell-derived astrocytes provides multiple benefits in a rat model of Parkinsons. EMBO Mol. Med. 6, 504\u2013518 (2014).","journal-title":"EMBO Mol. Med."},{"key":"94188_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/JCI93924","volume":"128","author":"JJ Song","year":"2018","unstructured":"Song, J. J. et al. Cografting astrocytes improves cell therapeutic outcomes in a Parkinson\u2019s disease model. J. Clin. Invest. 128, 463\u2013482 (2018).","journal-title":"J. Clin. Invest."},{"key":"94188_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-6606-3-12","volume":"3","author":"XL Gu","year":"2010","unstructured":"Gu, X. L. et al. Astrocytic expression of Parkinson\u2019s disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol. Brain 3, 12 (2010).","journal-title":"Mol. Brain"},{"key":"94188_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00609","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Generation of a novel mouse model of Parkinson\u2019s disease via targeted knockdown of glutamate transporter GLT-1 in the substantia Nigra. ACS Chem. Neurosci. https:\/\/doi.org\/10.1021\/acschemneuro.9b00609 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"94188_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13243-0","author":"Y Fujii","year":"2017","unstructured":"Fujii, Y., Maekawa, S. & Morita, M. Astrocyte calcium waves propagate proximally by gap junction and distally by extracellular diffusion of ATP released from volume-regulated anion channels. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-13243-0 (2017).","journal-title":"Sci. Rep."},{"key":"94188_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1042\/BJ20051922","volume":"394","author":"DW Laird","year":"2006","unstructured":"Laird, D. W. Life cycle of connexins in health and disease. J. Biochem. 394, 527\u2013543 (2006).","journal-title":"J. Biochem."},{"key":"94188_CR24","first-page":"1","volume":"2301756","author":"N Hastings","year":"2023","unstructured":"Hastings, N. et al. Electrophysiological in vitro study of long-range signal transmission by astrocytic networks. Adv. Sci. 2301756, 1\u201316 (2023).","journal-title":"Adv. Sci."},{"key":"94188_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0165-0173(99)00066-1","volume":"32","author":"JI Nagy","year":"2000","unstructured":"Nagy, J. I. & Rash, J. E. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res. Rev. 32, 29\u201344 (2000).","journal-title":"Brain Res. Rev."},{"key":"94188_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.01.080","author":"A Kawasaki","year":"2009","unstructured":"Kawasaki, A. et al. Modulation of connexin 43 in rotenone-induced model of Parkinson\u2019s disease. Neuroscience https:\/\/doi.org\/10.1016\/j.neuroscience.2009.01.080 (2009).","journal-title":"Neuroscience"},{"key":"94188_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2013.1535","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Wu, Z., Liu, X. & Fu, Q. Gastrodin ameliorates Parkinson\u2019s disease by downregulating connexin 43. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2013.1535 (2013).","journal-title":"Mol. Med. Rep."},{"key":"94188_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19961201)46:5<606::AID-JNR9>3.0.CO;2-N","author":"M Rufer","year":"1996","unstructured":"Rufer, M. et al. Regulation of connexin-43, GFAP, and FGF-2 is not accompanied by changes in astroglial coupling in MPTP-lesioned, FGF-2-treated parkinsonian mice. J. Neurosci. Res. https:\/\/doi.org\/10.1002\/(SICI)1097-4547(19961201)46:5%3c606::AID-JNR9%3e3.0.CO;2-N (1996).","journal-title":"J. Neurosci. Res."},{"key":"94188_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10517-023-05772-8","volume":"174","author":"DN Voronkov","year":"2023","unstructured":"Voronkov, D. N., Stavrovskaya, A. V., Potapov, I. A., Guschina, A. S. & Olshanskiy, A. S. Glial reaction in a neuroinflammatory model of Parkinson\u2019s disease. Bull. Exp. Biol. Med. 174, 693\u2013698 (2023).","journal-title":"Bull. Exp. Biol. Med."},{"key":"94188_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-010-9560-6","author":"S Zhang","year":"2011","unstructured":"Zhang, S. et al. Reversal of rotenone-induced dysfunction of astrocytic connexin43 by opening mitochondrial ATP-sensitive potassium channels. Cell. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s10571-010-9560-6 (2011).","journal-title":"Cell. Mol. Neurobiol."},{"key":"94188_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/glia.23631","volume":"67","author":"EF D\u00edaz","year":"2019","unstructured":"D\u00edaz, E. F. et al. Connexin 43 hemichannels and pannexin-1 channels contribute to the \u03b1-synuclein-induced dysfunction and death of astrocytes. Glia 67, 1598\u20131619 (2019).","journal-title":"Glia"},{"issue":"3","key":"94188_CR32","first-page":"421","volume":"54","author":"H Quan","year":"2022","unstructured":"Quan, H. et al. Inhibition connexin 43 by mimetic peptide Gap27 mediates protective effects on 6-hydroxydopamine induced Parkinson\u2019s disease mouse model. J. Peking Univ. Health Sci. 54(3), 421\u2013426 (2022).","journal-title":"J. Peking Univ. Health Sci."},{"key":"94188_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136471","volume":"771","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Connexin43 inhibition attenuated dopaminergic neuronal loss in the lipopolysaccharide-induced mice model of Parkinson\u2019s disease. Neurosci. Lett. 771, 136471 (2022).","journal-title":"Neurosci. Lett."},{"key":"94188_CR34","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1126\/science.adc9020","volume":"378","author":"F Endo","year":"2022","unstructured":"Endo, F. et al. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science. 378, 6619 (2022).","journal-title":"Science."},{"key":"94188_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-024-07138-0","volume":"627","author":"M Ollivier","year":"2024","unstructured":"Ollivier, M. et al. Crym-positive striatal astrocytes gate perseverative behaviour. Nature 627, 358\u2013366 (2024).","journal-title":"Nature"},{"key":"94188_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-023-06502-w","volume":"622","author":"R de Ceglia","year":"2023","unstructured":"de Ceglia, R. et al. Specialized astrocytes mediate glutamatergic gliotransmission in the CNS. Nature 622, 120\u2013129 (2023).","journal-title":"Nature"},{"key":"94188_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20870","author":"GDV Sagar","year":"2006","unstructured":"Sagar, G. D. V. & Larson, D. M. Carbenoxolone inhibits junctional transfer and upregulates Connexin43 expression by a protein kinase A-dependent pathway. J. Cell. Biochem. https:\/\/doi.org\/10.1002\/jcb.20870 (2006).","journal-title":"J. Cell. Biochem."},{"key":"94188_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0150-3","author":"L Maatouk","year":"2018","unstructured":"Maatouk, L. et al. Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-018-0150-3 (2018).","journal-title":"Cell Death Differ."},{"key":"94188_CR39","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1242\/jcs.200667","volume":"130","author":"TM Ribeiro-Rodrigues","year":"2017","unstructured":"Ribeiro-Rodrigues, T. M., Martins-Marques, T., Morel, S., Kwak, B. R. & Gir\u00e3o, H. Role of connexin 43 in different forms of intercellular communication, gap junctions, extracellular vesicles and tunnelling nanotubes. J. Cell Sci. 130, 3619\u20133630 (2017).","journal-title":"J. Cell Sci."},{"key":"94188_CR40","doi-asserted-by":"publisher","first-page":"17011","DOI":"10.1038\/s41598-020-73892-6","volume":"10","author":"S McCutcheon","year":"2020","unstructured":"McCutcheon, S., Stout, R. F. Jr. & Spray, D. C. The dynamic Nexus: gap junctions control protein localization and mobility in distinct and surprising ways. Sci. Rep. 10, 17011 (2020).","journal-title":"Sci. Rep."},{"key":"94188_CR41","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1523\/JNEUROSCI.3199-16.2017","volume":"37","author":"W Sun","year":"2017","unstructured":"Sun, W. et al. SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions. J. Neurosci. 37, 4493\u20134507 (2017).","journal-title":"J. Neurosci."},{"key":"94188_CR42","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1083\/jcb.115.5.1357","volume":"115","author":"LS Musil","year":"1991","unstructured":"Musil, L. S. & Goodenough, D. A. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J. Cell Biol. 115, 1357\u20131374 (1991).","journal-title":"J. Cell Biol."},{"key":"94188_CR43","doi-asserted-by":"publisher","first-page":"15097","DOI":"10.1074\/jbc.RA120.013705","volume":"295","author":"M Maulik","year":"2020","unstructured":"Maulik, M. et al. Amyloid-b regulates gap junction protein connexin 43 trafficking in cultured primary astrocytes. J. Biol. Chem. 295, 15097\u201315111 (2020).","journal-title":"J. Biol. Chem."},{"key":"94188_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli, A., Camacho, M., Allinson, K. & Williams-Gray, C. H. Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathol. Commun. 8, 1\u201319 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"94188_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-021-00175-w","volume":"7","author":"P Ramos-Gonzalez","year":"2021","unstructured":"Ramos-Gonzalez, P. et al. Astrocytic atrophy as a pathological feature of Parkinson\u2019s disease with LRRK2 mutation. NPJ Park. Dis. 7, 31 (2021).","journal-title":"NPJ Park. Dis."},{"key":"94188_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan, A. et al. Unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution. Mol. Neurodegener. 19, 7 (2024).","journal-title":"Mol. Neurodegener."},{"key":"94188_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128651","volume":"10","author":"AA Dijkstra","year":"2015","unstructured":"Dijkstra, A. A. et al. Evidence for immune response, axonal dysfunction and reduced endocytosis in the substantia Nigra in early stage Parkinson\u2019s disease. PLoS One 10, e0128651 (2015).","journal-title":"PLoS One"},{"key":"94188_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28871","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji, O. R., Behnam, M., Pourattar, M. A., Jafarpour, H. & Asemi, Z. Aquaporin 4: a key player in Parkinson\u2019s disease. J. Cell. Physiol. https:\/\/doi.org\/10.1002\/jcp.28871 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"2106","key":"94188_CR49","first-page":"e1","volume":"32","author":"J Gao","year":"2011","unstructured":"Gao, J. et al. Apolipoprotein E genotypes and the risk of Parkinson disease. Neurobiol. Dis. 32(2106), e1-2106.e6 (2011).","journal-title":"Neurobiol. Dis."},{"key":"94188_CR50","doi-asserted-by":"publisher","first-page":"7181","DOI":"10.3390\/ijms21197181","volume":"21","author":"C Lenzi","year":"2020","unstructured":"Lenzi, C. et al. The down-regulation of clusterin expression enhances the \u03b1Synuclein aggregation process. Int. J. Mol. Sci. 21, 7181 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"94188_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.240","volume":"8","author":"J Zou","year":"2017","unstructured":"Zou, J. et al. Cystatin C as a potential therapeutic mediator against Parkinson\u2019s disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units. Cell Death Dis. 8, e2854 (2017).","journal-title":"Cell Death Dis."},{"issue":"12","key":"94188_CR52","doi-asserted-by":"publisher","first-page":"e973","DOI":"10.1038\/tp.2016.237","volume":"6","author":"Y Cheng","year":"2016","unstructured":"Cheng, Y. et al. A human carboxypeptidase E\/NF-\u03b11 gene mutation in an Alzheimer\u2019s disease patient leads to dementia and depression in mice. Transl. Psychiatry 6(12), e973 (2016).","journal-title":"Transl. Psychiatry"},{"key":"94188_CR53","doi-asserted-by":"publisher","first-page":"Inad015","DOI":"10.1093\/lifemedi\/lnad015","volume":"2","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Restoring carboxypeptidase E rescues BDNF maturation and neurogenesis in aged brains. Life Med. 2, Inad015 (2023).","journal-title":"Life Med."},{"key":"94188_CR54","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/hep.22716","volume":"49","author":"RG Ruddell","year":"2009","unstructured":"Ruddell, R. G. et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49, 887\u2013900 (2009).","journal-title":"Hepatology"},{"key":"94188_CR55","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1038\/s41467-023-41539-5","volume":"14","author":"Y He","year":"2023","unstructured":"He, Y. et al. Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents. Nat. Commun. 14, 5804 (2023).","journal-title":"Nat. Commun."},{"key":"94188_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw071","author":"C Nagy","year":"2017","unstructured":"Nagy, C., Torres-Platas, S. G., Mechawar, N. & Turecki, G. Repression of astrocytic connexins in cortical and subcortical brain regions and prefrontal enrichment of H3K9me3 in depression and suicide. Int. J. Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyw071 (2017).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"94188_CR57","doi-asserted-by":"publisher","first-page":"247054701881418","DOI":"10.1177\/2470547018814186","volume":"2","author":"JJ Miguel-Hidalgo","year":"2018","unstructured":"Miguel-Hidalgo, J. J., Moulana, M., Deloach, P. H. & Rajkowska, G. Chronic unpredictable stress reduces immunostaining for Connexins 43 and 30 and myelin basic protein in the rat Prelimbic and orbitofrontal cortices. Chronic Stress 2, 2470547018814186 (2018).","journal-title":"Chronic Stress"},{"key":"94188_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.319","author":"JD Sun","year":"2012","unstructured":"Sun, J. D., Liu, Y., Yuan, Y. H., Li, J. & Chen, N. H. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology https:\/\/doi.org\/10.1038\/npp.2011.319 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"94188_CR59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3389\/fncel.2015.00495","volume":"9","author":"T Jeanson","year":"2016","unstructured":"Jeanson, T. et al. Antidepressants impact connexin 43 channel functions in astrocytes. Front. Cell. Neurosci. 9, 495 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"94188_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12614","author":"N Morioka","year":"2014","unstructured":"Morioka, N. et al. Amitriptyline up-regulates connexin43-gap junction in rat cultured cortical astrocytes via activation of the p38 and c-Fos\/AP-1 signalling pathway. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.12614 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"94188_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.04.007","author":"JJ Miguel-Hidalgo","year":"2014","unstructured":"Miguel-Hidalgo, J. J. et al. Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression. J. Psychiatr. Res. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.04.007 (2014).","journal-title":"J. Psychiatr. Res."},{"key":"94188_CR62","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/0269881108091074","volume":"23","author":"J Miguel-Hidalgo","year":"2009","unstructured":"Miguel-Hidalgo, J., Shoyama, Y. & Wanzo, V. Infusion of gliotoxins or a gap junction blocker in the prelimbic cortex increases alcohol preference in Wistar rats. J. Psychopharmacol. 23, 550\u2013557 (2009).","journal-title":"J. Psychopharmacol."},{"key":"94188_CR63","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00221-023-06587-9","volume":"241","author":"X Wu","year":"2023","unstructured":"Wu, X., Li, L., Zhou, B., Wang, J. & Shao, W. Connexin 43 regulates astrocyte dysfunction and cognitive deficits in early life stress-treated mice. Exp. Brain Res. 241, 1207\u20131214 (2023).","journal-title":"Exp. Brain Res."},{"key":"94188_CR64","doi-asserted-by":"crossref","unstructured":"Quesseveur, G. et al. Attenuated levels of hippocampal Connexin 43 and its phosphorylation correlate with antidepressant- and anxiolytic-like activities in mice. Front. Cell. Neurosci. 9, (2015).","DOI":"10.3389\/fncel.2015.00490"},{"key":"94188_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22877","author":"BC Avenda\u00f1o","year":"2015","unstructured":"Avenda\u00f1o, B. C., Montero, T. D., Ch\u00e1vez, C. E., von Bernhardi, R. & Orellana, J. A. Prenatal exposure to inflammatory conditions increases Cx43 and Panx1 unopposed channel opening and activation of astrocytes in the offspring effect on neuronal survival. Glia https:\/\/doi.org\/10.1002\/glia.22877 (2015).","journal-title":"Glia"},{"key":"94188_CR66","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","volume":"13","author":"L Marsh","year":"2013","unstructured":"Marsh, L. Depression and Parkinson\u2019s disease: Current knowledge. Curr. Neurol. Neurosci. Rep. 13, 409 (2013).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"4","key":"94188_CR67","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/molecules28041820","volume":"28","author":"H Jiang","year":"2023","unstructured":"Jiang, H., Zhang, Y., Wang, Z.-Z. & Chen, N.-H. Connexin 43: An interface connecting neuroinflammation to depression. Molecules 28(4), 1820 (2023).","journal-title":"Molecules"},{"key":"94188_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","volume":"246","author":"JC Felger","year":"2013","unstructured":"Felger, J. C. & Lotrich, F. E. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience 246, 199\u2013229 (2013).","journal-title":"Neuroscience"},{"key":"94188_CR69","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller, A. H., Maletic, V. & Raison, C. L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65, 732\u2013741 (2009).","journal-title":"Biol. Psychiatry"},{"key":"94188_CR70","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/14728222.2019.1673368","volume":"23","author":"OO Mugisho","year":"2019","unstructured":"Mugisho, O. O., Rupenthal, I. D., Paquet-Durand, F., Acosta, M. L. & Green, C. R. Targeting connexin hemichannels to control the inflammasome: The correlation between connexin43 and NLRP3 expression in chronic eye disease. Expert Opin. Ther. Targets 23, 855\u2013863 (2019).","journal-title":"Expert Opin. Ther. Targets"},{"key":"94188_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.01.016","author":"CK Liao","year":"2010","unstructured":"Liao, C. K., Wang, S. M., Chen, Y. L., Wang, H. S. & Wu, J. C. Lipopolysaccharide-induced inhibition of connexin43 gap junction communication in astrocytes is mediated by downregulation of caveolin-3. Int. J. Biochem. Cell Biol. https:\/\/doi.org\/10.1016\/j.biocel.2010.01.016 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"94188_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-021-00868-6","volume":"14","author":"G Panattoni","year":"2021","unstructured":"Panattoni, G. et al. Diverse inflammatory threats modulate astrocytes Ca2+ signaling via connexin43 hemichannels in organotypic spinal slices. Mol. Brain 14, 1\u201315 (2021).","journal-title":"Mol. Brain"},{"key":"94188_CR73","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.28015","volume":"35","author":"RS Wijeyekoon","year":"2020","unstructured":"Wijeyekoon, R. S. et al. Cerebrospinal fluid cytokines and neurodegeneration-associated proteins in Parkinson\u2019s disease. Mov. Disord. 35, 1062\u20131066 (2020).","journal-title":"Mov. Disord."},{"key":"94188_CR74","doi-asserted-by":"crossref","unstructured":"Ho, M. S. Microglia in Parkinson\u2019s Disease. in Neuroglia in Neurodegenerative Diseases 335\u2013353 (2019).","DOI":"10.1007\/978-981-13-9913-8_13"},{"key":"94188_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pneurobio.2009.02.004","volume":"88","author":"I Ferrer","year":"2009","unstructured":"Ferrer, I. Early involvement of the cerebral cortex in Parkinson\u2019s disease: Convergence of multiple metabolic defects. Prog. Neurobiol. 88, 89\u2013103 (2009).","journal-title":"Prog. Neurobiol."},{"key":"94188_CR76","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fphar.2020.00212","volume":"11","author":"R Ramadan","year":"2020","unstructured":"Ramadan, R. et al. Connexin43 hemichannel targeting With TAT-Gap19 alleviates radiation-induced endothelial cell damage. Front. Pharmacol. 11, 212 (2020).","journal-title":"Front. Pharmacol."},{"key":"94188_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.08.022","author":"J Clasadonte","year":"2017","unstructured":"Clasadonte, J., Scemes, E., Wang, Z., Boison, D. & Haydon, P. G. Connexin 43-mediated Astroglial metabolic networks contribute to the regulation of the sleep-wake cycle. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2017.08.022 (2017).","journal-title":"Neuron"},{"key":"94188_CR78","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.82206","volume":"11","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Connexin 43 hemichannels regulate mitochondrial ATP generation, mobilization, and mitochondrial homeostasis against oxidative stress. Elife 11, e82206 (2022).","journal-title":"Elife"},{"key":"94188_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.856867","volume":"13","author":"S Yang","year":"2022","unstructured":"Yang, S. et al. Aquaporin-4, Connexin-30, and Connexin-43 as biomarkers for decreased objective sleep quality and\/or cognition dysfunction in patients with chronic insomnia disorder. Front. Psychiatry 13, 856867 (2022).","journal-title":"Front. Psychiatry"},{"key":"94188_CR80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.nbd.2011.12.040","volume":"46","author":"K McDowell","year":"2012","unstructured":"McDowell, K. & Chesselet, M.-F. Animal models of the non-motor features of Parkinson\u2019s disease. Neurobiol. Dis. 46, 597\u2013606 (2012).","journal-title":"Neurobiol. Dis."},{"key":"94188_CR81","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.061","author":"JL McClain","year":"2014","unstructured":"McClain, J. L. et al. Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2013.10.061 (2014).","journal-title":"Gastroenterology"},{"key":"94188_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22663","author":"KK Ball","year":"2011","unstructured":"Ball, K. K., Harik, L., Gandhi, G. K., Cruz, N. F. & Dienel, G. A. Reduced gap junctional communication among astrocytes in experimental diabetes: Contributions of altered connexin protein levels and oxidative-nitrosative modifications. J. Neurosci. Res. https:\/\/doi.org\/10.1002\/jnr.22663 (2011).","journal-title":"J. Neurosci. Res."},{"key":"94188_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-14198-8","volume":"11","author":"MY Batiuk","year":"2020","unstructured":"Batiuk, M. Y. et al. Identification of region-specific astrocyte subtypes at single cell resolution. Nat. Commun. 11, 1\u201315 (2020).","journal-title":"Nat. Commun."},{"key":"94188_CR84","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/jce.12833","volume":"27","author":"MMJ Nassal","year":"2016","unstructured":"Nassal, M. M. J. et al. Phosphorylation at connexin43 serine-368 is necessary for myocardial conduction during metabolic stress. J. Cardiovasc. Electrophysiol. 27, 110\u2013119 (2016).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"94188_CR85","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200707060","author":"JL Solan","year":"2007","unstructured":"Solan, J. L. et al. Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents downregulation by PKC. J. Cell Biol. https:\/\/doi.org\/10.1083\/jcb.200707060 (2007).","journal-title":"J. Cell Biol."},{"issue":"3","key":"94188_CR86","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20070550","volume":"408","author":"GE Sosinsky","year":"2007","unstructured":"Sosinsky, G. E. et al. The C-terminus of connexin43 adopts different conformations in the Golgi and gap junction as detected with structure-specific antibodies. Biochem. J. 408(3), 375\u2013385 (2007).","journal-title":"Biochem. J."},{"key":"94188_CR87","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1523\/JNEUROSCI.4707-08.2009","volume":"29","author":"NA Oberheim","year":"2009","unstructured":"Oberheim, N. A. et al. Uniquely hominid features of adult human astrocytes. J. Neurosci. 29, 3276\u20133287 (2009).","journal-title":"J. Neurosci."},{"key":"94188_CR88","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tins.2006.08.004","volume":"29","author":"NA Oberheim","year":"2006","unstructured":"Oberheim, N. A., Wang, X., Goldman, S. & Nedergaard, M. Astrocytic complexity distinguishes the human brain. Trends Neurosci. 29, 547\u2013553 (2006).","journal-title":"Trends Neurosci."},{"issue":"1","key":"94188_CR89","doi-asserted-by":"publisher","first-page":"8380","DOI":"10.1038\/s41467-023-44192-0","volume":"14","author":"A Popov","year":"2023","unstructured":"Popov, A. et al. Mitochondrial malfunction and atrophy of astrocytes in the aged human cerebral cortex. Nat. Commun. 14(1), 8380 (2023).","journal-title":"Nat. Commun."},{"key":"94188_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.13334","volume":"20","author":"A Popov","year":"2021","unstructured":"Popov, A. et al. Astrocyte dystrophy in ageing brain parallels impaired synaptic plasticity. Aging Cell 20, 1\u201314 (2021).","journal-title":"Aging Cell"},{"key":"94188_CR91","unstructured":"R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2022)."},{"key":"94188_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21706-2","volume-title":"Modern applied statistics with S","author":"WN Veneables","year":"2002","unstructured":"Veneables, W. N. & Ripley, B. D. Modern applied statistics with S (Springer, 2002)."},{"key":"94188_CR93","unstructured":"Fox, J. & Weisberg, S. An {R} Companion to Applied Regression. (Sage, 2019)."},{"key":"94188_CR94","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"94188_CR95","first-page":"1","volume":"56","author":"MS Ben-Shachar","year":"2020","unstructured":"Ben-Shachar, M. S., L\u00fcdecke, D. & Makowski, D. effectsize: Estimation of effect size indices and standardized parameters. J. Open Source Softw. 56, 1\u20137 (2020).","journal-title":"J. Open Source Softw."},{"key":"94188_CR96","unstructured":"Field, A. Discovering statistics using IBM SPSS Statistics. (Sage, 2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94188-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94188-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94188-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T21:07:00Z","timestamp":1743196020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94188-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94188"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94188-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N.H. is a director; N.H., S.R., and P.A.S. are shareholders in \u201cCellestial Health Ltd.\u201d, a spin-off company from the University of Cambridge that explores astrocytic networks as therapeutic targets in Parkinson\u2019s disease and other conditions of the brain. The spin-off was created as a result of the academic work, including the results presented herewith. The other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"10250"}}